Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BU.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BU.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EW.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EW.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EW.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EW.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
BE.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BW.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BW.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BW.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BW.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FB.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FB.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FB.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-16988.9US
BQ.1.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BF.7.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used